Nonspecific phagocytic activity in rats infected with Plasmodium berghei and treated with amodiaquine or chloroquine.
D000655:Amodiaquine / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001835:Body Weight; D002244:Carbon; D002738:Chloroquine / Q000494:pharmacology* / Q000627:therapeutic use; D003102:Colloids; D007275:Injections, Intravenous; D008099:Liver / Q000276:immunology; D008168:Lung / Q000276:immunology; D008288:Malaria / Q000097:blood / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D008297:Male; D010587:Phagocytosis / Q000187:drug effects*; D010961:Plasmodium / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification; D051381:Rats; D013045:Species Specificity; D013154:Spleen / Q000276:immunology
D003102:Colloids; D000655:Amodiaquine; D002244:Carbon; D002738:Chloroquine